Expansion of Clinical Development of RVU120 in Low-Risk Myelodysplastic Syndromes (LR-MDS)

Ryvu Therapeutics announced that it entered into a Clinical Trial Financial Support agreement for an investigator initiated clinical trial with the European EMSCO network.